Pleased to join this distinguished group of authors in paying tribute to the great John Iglehart, founding editor of Health Affairs, who passed away in June. tinyurl.com/47rnt9yf @tuftscevr.bsky.social @healthaffairs.bsky.social

New Tufts-CEVR research led by @pattysynnott.bsky.social highlights: - high out-of-pocket costs of older adults living with dementia - financial risks increase in advanced dementia states. alz-journals.onlinelibrary.wiley.com/doi/10.1002/... #Alzheimers #dementia

In this just published paper in Value in Health led by Feng Xie and colleagues, we reviewed the published cost-effectiveness evidence for the 15 drugs selected for IPAY 2027 Medicare negotiations. @djvanness.bsky.social @ankurfactorial.bsky.social www.valueinhealthjournal.com/article/S109...

@icer-review.bsky.social @tuftscevr.bsky.social @peterneumann11.bsky.social @pattysynnott.bsky.social

Welcome, Dave!

CEVR is thrilled to welcome David Strutton, PhD, as a Senior Fellow! Dr. Strutton brings 30+ years of global leadership in health policy, biopharma, and HTA. His expertise in real-world evidence and access strategy will be a tremendous asset. Read more at: tinyurl.com/3bz9te3p

Excited to announce that David Strutton, Ph.D., a distinguished leader in healthcare policy, biopharmaceuticals, #vaccines, and #healtheconomics is joining Tufts-CEVR as a Senior Fellow. Announcement here: cevr.tuftsmedicalcenter.org/news/david-s... @tuftscevr.bsky.social

Great application of our CEA Registry at the #Vanderbilt Center for Health Economic Modeling: 11 international fellows from #LMICs used the Registry to conduct CEAs of public health interventions. Read more at: tinyurl.com/88varaue @peterneumann11.bsky.social #ISPOR

New in JCER: CEVR’s Meng Li and @peterneumann11.bsky.social call for more value assessment of health services/procedures. These interventions are ~70% of health care spending but are often implemented without robust evidence and, unlike drugs, can cost more over time. Read: tinyurl.com/ycxrppby

Two weeks left to apply: Earn your #HEOR Certificate online from @tufts.edu with globally-recognized faculty like @peterneumann11.bsky.social, @dano-hta.bsky.social, James Chambers, and more from CEVR. Apply today! Deadline is Aug. 1. tinyurl.com/pr6drkhf #RWE #pharma

Larry Mose, MSc is today’s #CEARegistry Summer fellow. Larry earned his MSc from @york.ac.uk and hopes to work in the field of #HEOR. Our thanks to the @moorefound.bsky.social ‬for funding the CEA Registry Fellowship program!‬‬

1/ How closely do health plans’ drug #utilizationmanagement (UM) policies align with #clinicalguidelines? CEVR and NPC examined policies for 389 drug-indication pairs from 18 commercial insurers. Here’s a thread on what we found:

Some personal reflections about John Iglehart (1939-1975), Founding Editor of Health Affairs. cevr.tuftsmedicalcenter.org/news/in-reme... @tuftscevr.bsky.social

New Tufts-CEVR paper in the J of Alzheimer's Disease, led by Paige Lin, provides updated health utility estimates for persons with AD and their caregivers across disease stages and settings. journals.sagepub.com/doi/10.1177/... @tuftscevr.bsky.social @pattysynnott.bsky.social #Alzheimers

Pleased to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, supported by the Gordon and Betty Moore Foundation. cevr.tuftsmedicalcenter.org/news/2025-ce... @tuftscevr.bsky.social @pattysynnott.bsky.social

CEVR is thrilled to introduce the 2025 cohort of the Tufts-CEVR CEA Registry Summer Fellowship Program, which is supported by the @moorefound.bsky.social. Stay tuned over the next two months for featured posts about each fellow! More details at: cevr.tuftsmedicalcenter.org/news/2025-ce...

Congrats, Mel!

New in Value in Health: three former CEA Registry Summer Fellows (Xujun Gu, Hanwen Zhang, and Divya Patil) and U of Maryland's Julia Slejko used the CEA Registry to explore the utility of AI-assisted data extraction. Read at tinyurl.com/37mh5n6m

ISPOR and CEVR are partnering to offer free premium access to the CEA Registry for students + academic/government researchers in LMICs. Unlock data from 14,000+ cost-effectiveness studies, advanced tools, and more. More at: tinyurl.com/5y3vpsz3 #HEOR #GlobalHealth #ISPOR

We're excited to announce Tufts-CEVR's new partnership with ISPOR to provide free, premium access to the CEA Registry for ISPOR members who are students or researchers in LMICs. More detail here: cevr.tuftsmedicalcenter.org/news/cevr-is... @djvanness.bsky.social @tuftscevr.bsky.social

With @tuftscevr.bsky.social colleagues #ISPORAnnual in Montreal.

Thanks to all my wonderful Tufts-CEVR colleagues for putting on another great annual meeting! Proud to work with you! @dano-hta.bsky.social @brianreid.bsky.social @tuftscevr.bsky.social @mollytoba.bsky.social

Congrats!

This right question about prevention: not whether it saves money, but whether it is worth the cost. tinyurl.com/3ezrrvm4 @tuftscevr.bsky.social #health #prevention

Reports about the death of QALYs is greatly exaggerated. My new blog post: cevr.tuftsmedicalcenter.org/news/the-dea... @dano-hta.bsky.social @tuftscevr.bsky.social #HEOR #QALYs

Medicare coverage policy for new technologies may change substantially in the new Administration. Our analysis here: tinyurl.com/yuj67caf @healthaffairs.bsky.social @tuftscevr.bsky.social @kathrynp-phd.bsky.social

How will Trump admin reform Medicare’s #CED program? Return to the #MCIT paradigm, default enrollment in #Medicare Advantage, etc? In HA Forefront: Tunis, Hatfield, Patel, & @peterneumann11.bsky.social argue against removing CED + for efficient data collection. Read: tinyurl.com/yuj67caf

Our new piece in @healthaffairs.bsky.social on #Medicare coverage of new technologies in this new era. Key points: - CMS shouldn't eliminate coverage w/ evid development - instead, efforts should focus on more efficient post-market evidence generation. tinyurl.com/yu4rzkr2 @tuftscevr.bsky.social

New study by my @tuftscevr.bsky.social colleague, Yolanda Zhu and colleagues. The #IRA #Medicare Part D benefit redesign may significantly lower OOP drug spending for beneficiaries with #dementia and comorbidities. tinyurl.com/5n8uxam3 #IRA #drugs

The #IRA #Medicare Part D benefit redesign may significantly lower OOP drug spending for beneficiaries with #dementia and multiple comorbidities. Read the new CEVR study in Value in Health for more details. authors.elsevier.com/a/1ke483vkP0...

This new podcast by Melanie Whittington interviewing @franksdavid.bsky.social provides a nice discussion about the use of models for investors and health economists. Well worth the listen. leerink.com/podcast/mana... @tuftscevr.bsky.social

Don't miss a chance to work with our renowned faculty! Applications for our 2025 CEA Registry Summer Fellowship close March 17th. Learn more / apply today: cevr.tuftsmedicalcenter.org/news/2025-ce... #internships #fellowship #healthecon @pattysynnott.bsky.social @peterneumann11.bsky.social

Thanks, @araymakers.bsky.social! @pattysynnott.bsky.social @dano-hta.bsky.social @tuftscevr.bsky.social @ankurfactorial.bsky.social

Good piece by @araymakers.bsky.social et al. using the Tufts CEA Registry: "Concerns over CEAs identifying subgroups in their analyses do not appear to be justified & does not warrant precluding the use of #QALYs for decision-making or price negotiation for drugs." @tuftscevr.bsky.social

We are now accepting applications for the our virtual Summer CEA Registry fellowship program. Learn more and apply here: cevr.tuftsmedicalcenter.org/news/2025-ce... #internships #fellowship #research #healthecon @tuftscevr.bsky.social @pattysynnott.bsky.social

Grad students: get a head start on summer by applying for our virtual CEA Registry fellowship. Learn more and apply today: cevr.tuftsmedicalcenter.org/news/2025-ce... #internships #fellowship #research #healthecon @pattysynnott.bsky.social

The best books I read in 2024. My annual list. tinyurl.com/yhs5h87v

Calling all health economists! The Tufts-CEVR Cost-Effectiveness Analysis Paper of the Year Contest is back! Submit your paper on cost-effectiveness analysis for a chance to win $500. Deadline: January 31, 2024. Don't miss out! Learn more & apply: tinyurl.com/yskfm9us #HEOR #CEA

The outlook for US payer coverage of specialty drugs in 2005. Register here for our webinar, Dec 4, 3-3:30 ET: tinyurl.com/2pndy8v8

Join us, Dec 4, 3-3:30 ET, as Tufts-CEVR's James Chambers discusses the outlook for US payer coverage of specialty drugs in 2025. Register here: lnkd.in/g_GuE7bh.

Just back from #ISPOREurope in Barcelona, where I discussed dynamic pricing in economic evaluation with @dano-hta.bsky.social Mark Sculpher & Beth Woods. (Also did some sightseeing with Sean Tunis.)

The final agenda for the 10/26 symposium in Boston, "Celebrating Cost-Effectiveness Analysis," is now available. Register in person or online: tinyurl.com/2ab38f9p